Last update
4/6/2026
Reviewed By
Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 6 Researches
7.3
USERS' SCORE
Good
Based on 3 Reviews
8.5
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Iron (elemental) (from 90 mg Ferrous Bisglycinate)(Ferrochel™)
18 mg
100%
Top Medical Research Studies
9
Alendronate reduces pain and improves BMD
We explored the effectiveness of alendronate, a common drug for osteoporosis, in treating bone pain and improving bone health in patients with thalassemia. This randomized controlled trial involved men and premenopausal women, who were given either alendronate or a placebo for 12 months.
We found that alendronate significantly improved bone mineral density and reduced back pain. Even better, the treatment was well tolerated with a good safety profile. Overall, our findings suggest that alendronate can be beneficial for those struggling with osteoporosis linked to thalassemia.
We found that alendronate significantly improved bone mineral density and reduced back pain. Even better, the treatment was well tolerated with a good safety profile. Overall, our findings suggest that alendronate can be beneficial for those struggling with osteoporosis linked to thalassemia.
Read More
8
We examined a case of a 32-year-old woman on long-term hemodialysis who experienced severe bone pain and fractures. Initial tests showed high levels of iron and aluminum. After treating her with deferoxamine—a chelating agent—her bone pain improved, and a follow-up biopsy showed better bone health. However, while her pain was managed, her iron and aluminum levels changed only slightly, highlighting the complexity of treating conditions linked to metal imbalances.
Read More
8
We explored how cancer in the bones, specifically from breast tumors, leads to severe pain due to increased levels of glutamate. In our research, we found that certain chemicals, including iron-based compounds, can reduce this glutamate release. This reduction helps alleviate pain symptoms in models of cancer-induced bone pain. While our findings suggest that targeting the glutamate pathway may be effective, we did not find that iron treatment alone significantly impacts bone pain management. Overall, this study highlights potential new avenues for treating pain associated with bone metastases.
Read More
Most Useful Reviews
9
Effective without discomfort
This iron supplement has effectively raised my ferritin levels within 10 days without causing bloating, stomach pain, or other typical side effects associated with iron. I took it with lunch, and it has proven to be a reliable option that I will continue to use.
Read More
9
Pain relief during periods
I take this during my period to alleviate pain. The quality is great, and the ingredients are safe. I will definitely return to buy them again.
Read More
7.5
No stomach cramps
Good, no cramping! My wife had anaemia and I got these which helped boost her iron levels without the pain of stomach cramps or nausea.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 6 Researches
7.3
- All Researches
9
Alendronate reduces pain and improves BMD
We explored the effectiveness of alendronate, a common drug for osteoporosis, in treating bone pain and improving bone health in patients with thalassemia. This randomized controlled trial involved men and premenopausal women, who were given either alendronate or a placebo for 12 months.
We found that alendronate significantly improved bone mineral density and reduced back pain. Even better, the treatment was well tolerated with a good safety profile. Overall, our findings suggest that alendronate can be beneficial for those struggling with osteoporosis linked to thalassemia.
We found that alendronate significantly improved bone mineral density and reduced back pain. Even better, the treatment was well tolerated with a good safety profile. Overall, our findings suggest that alendronate can be beneficial for those struggling with osteoporosis linked to thalassemia.
Read More
8
We explored how cancer in the bones, specifically from breast tumors, leads to severe pain due to increased levels of glutamate. In our research, we found that certain chemicals, including iron-based compounds, can reduce this glutamate release. This reduction helps alleviate pain symptoms in models of cancer-induced bone pain. While our findings suggest that targeting the glutamate pathway may be effective, we did not find that iron treatment alone significantly impacts bone pain management. Overall, this study highlights potential new avenues for treating pain associated with bone metastases.
Read More
8
We examined a case of a 32-year-old woman on long-term hemodialysis who experienced severe bone pain and fractures. Initial tests showed high levels of iron and aluminum. After treating her with deferoxamine—a chelating agent—her bone pain improved, and a follow-up biopsy showed better bone health. However, while her pain was managed, her iron and aluminum levels changed only slightly, highlighting the complexity of treating conditions linked to metal imbalances.
Read More
7
We examined the long-term safety and effectiveness of luspatercept in adult patients with β-thalassemia, a genetic blood disorder that leads to anemia. The study involved a diverse group of 64 patients, analyzing how well luspatercept could help increase hemoglobin levels and reduce blood transfusions over an extended period.
Importantly, while luspatercept showed significant benefits, common side effects included mild headaches and bone pain. However, these symptoms did not emerge as major concerns, and patients reported manageable experiences overall.
Our findings suggest luspatercept can be a valuable treatment for both transfusion-dependent and nontransfusion-dependent β-thalassemia patients.
Importantly, while luspatercept showed significant benefits, common side effects included mild headaches and bone pain. However, these symptoms did not emerge as major concerns, and patients reported manageable experiences overall.
Our findings suggest luspatercept can be a valuable treatment for both transfusion-dependent and nontransfusion-dependent β-thalassemia patients.
Read More
7
We explored the connection between bone pain and iron treatment in patients on maintenance hemodialysis. In our observation, two patients suffered from bone pain related to aluminum and iron-related bone disease, which was alleviated by deferoxamine therapy.
However, we also noted that three patients experienced transverse fractures under normal daily activities. This indicates that both aluminum and iron-related diseases can weaken bone, leading to fractures even with minimal stress.
However, we also noted that three patients experienced transverse fractures under normal daily activities. This indicates that both aluminum and iron-related diseases can weaken bone, leading to fractures even with minimal stress.
Read More
User Reviews
USERS' SCORE
Good
Based on 3 Reviews
8.5
- All Reviews
- Positive Reviews
- Negative Reviews
9
Effective without discomfort
This iron supplement has effectively raised my ferritin levels within 10 days without causing bloating, stomach pain, or other typical side effects associated with iron. I took it with lunch, and it has proven to be a reliable option that I will continue to use.
Read More
9
Pain relief during periods
I take this during my period to alleviate pain. The quality is great, and the ingredients are safe. I will definitely return to buy them again.
Read More
7.5
No stomach cramps
Good, no cramping! My wife had anaemia and I got these which helped boost her iron levels without the pain of stomach cramps or nausea.
Read More
Frequently Asked Questions
9
Effective without discomfort
This iron supplement has effectively raised my ferritin levels within 10 days without causing bloating, stomach pain, or other typical side effects associated with iron. I took it with lunch, and it has proven to be a reliable option that I will continue to use.
9
Pain relief during periods
I take this during my period to alleviate pain. The quality is great, and the ingredients are safe. I will definitely return to buy them again.
7.5
No stomach cramps
Good, no cramping! My wife had anaemia and I got these which helped boost her iron levels without the pain of stomach cramps or nausea.
9
Alendronate reduces pain and improves BMD
We explored the effectiveness of alendronate, a common drug for osteoporosis, in treating bone pain and improving bone health in patients with thalassemia. This randomized controlled trial involved men and premenopausal women, who were given either alendronate or a placebo for 12 months.
We found that alendronate significantly improved bone mineral density and reduced back pain. Even better, the treatment was well tolerated with a good safety profile. Overall, our findings suggest that alendronate can be beneficial for those struggling with osteoporosis linked to thalassemia.
We found that alendronate significantly improved bone mineral density and reduced back pain. Even better, the treatment was well tolerated with a good safety profile. Overall, our findings suggest that alendronate can be beneficial for those struggling with osteoporosis linked to thalassemia.
5
We reviewed various treatments for osteoporosis in individuals with beta-thalassemia to see how they alleviate bone pain. Among the treatments, bisphosphonates showed potential for increasing bone density, while zinc supplementation was likely to enhance site-specific bone mass.
Notably, denosumab and strontium ranelate appeared to significantly reduce bone pain measured on a scale, indicating improved quality of life. However, the overall evidence certainty was low, emphasizing a need for more extensive trials. There's promise, but further research is essential to draw firmer conclusions.
Notably, denosumab and strontium ranelate appeared to significantly reduce bone pain measured on a scale, indicating improved quality of life. However, the overall evidence certainty was low, emphasizing a need for more extensive trials. There's promise, but further research is essential to draw firmer conclusions.
8
We examined a case of a 32-year-old woman on long-term hemodialysis who experienced severe bone pain and fractures. Initial tests showed high levels of iron and aluminum. After treating her with deferoxamine—a chelating agent—her bone pain improved, and a follow-up biopsy showed better bone health. However, while her pain was managed, her iron and aluminum levels changed only slightly, highlighting the complexity of treating conditions linked to metal imbalances.
7
We explored the connection between bone pain and iron treatment in patients on maintenance hemodialysis. In our observation, two patients suffered from bone pain related to aluminum and iron-related bone disease, which was alleviated by deferoxamine therapy.
However, we also noted that three patients experienced transverse fractures under normal daily activities. This indicates that both aluminum and iron-related diseases can weaken bone, leading to fractures even with minimal stress.
However, we also noted that three patients experienced transverse fractures under normal daily activities. This indicates that both aluminum and iron-related diseases can weaken bone, leading to fractures even with minimal stress.
References
- Piriyakhuntorn P, Tantiworawit A, Phimphilai M, Srichairatanakool S, Teeyasoontranon W, et al. The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial. Front Endocrinol (Lausanne). 2023;14:1178761. 10.3389/fendo.2023.1178761
- Bhardwaj A, Swe KMM, Sinha NK. Treatment for osteoporosis in people with beta-thalassaemia. Cochrane Database Syst Rev. 2023;5:CD010429. 10.1002/14651858.CD010429.pub3
- Piga A, Longo F, Gamberini MR, Voskaridou E, Ricchi P, et al. Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia. Ther Adv Hematol. 2022;13:20406207221134404. 10.1177/20406207221134404
- Slosky LM, BassiriRad NM, Symons AM, Thompson M, Doyle T, et al. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain. Pain. 2016;157:2605. 10.1097/j.pain.0000000000000681
- Yamagata K, Kobayashi M, Koyama A, Narita M, Amagai H, et al. [A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient]. Nihon Jinzo Gakkai Shi. 1991;33:437. PubMed
- Marumo F, Nomura T, Nishikawa H. Transverse fractures of the spinous process of the 7th cervical vertebra in RDT patients: an Al related disease?. Int J Artif Organs. 1987;10:93. PubMed
Data last updated:
